# Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-26-064
- **Status:** forecasted
- **Opens:** September 9, 2025
- **CFDA:** 93.395
- **View on Kontrakk:** https://kontrakk.com/grants/360541

## Description

No description provided.